bozkaya, y. Et Al. 2018. A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer. Asian Pacific Journal Of Cancer Prevention , vol.19, no.1 , 283-290.

bozkaya, y., ÖZDEMİR, N., YAZICI, O., demirci, n. s. , kurtipek, a., erdem, g. u. , ... Ergün, Y.(2018). A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer. Asian Pacific Journal Of Cancer Prevention , vol.19, no.1, 283-290.

bozkaya, yakup Et Al. "A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer," Asian Pacific Journal Of Cancer Prevention , vol.19, no.1, 283-290, 2018

bozkaya, yakup Et Al. "A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer." Asian Pacific Journal Of Cancer Prevention , vol.19, no.1, pp.283-290, 2018

bozkaya, y. Et Al. (2018) . "A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer." Asian Pacific Journal Of Cancer Prevention , vol.19, no.1, pp.283-290.

@article{article, author={yakup bozkaya Et Al. }, title={A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer}, journal={Asian Pacific Journal Of Cancer Prevention}, year=2018, pages={283-290} }